Abcam’s acquisition comes two months after its board announced the exploration of strategic alternatives that could include the sale of the company. Danaher beat out at least 20 companies that were potential buyers of the life sciences tools and antibody development firm.
Massachusetts Institute of Technology Bioengineering Professor Ram Sasisekharan and his lab have been cleared of research misconduct allegations following a lengthy university investigation.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
News from innovative healthcare startups from Specifica, Aerovate Therapeutics and more.
Compass Therapeutics, formed by leadership at fellow antibody discovery company Adimab, is raising $120 million.
Cambridge startup Siamab Therapeutics has changed up its direction, now developing monoclonal antibodies to hinder the progressive growth of tumors. The company just received another $2 million in funding, largely from angel investors, rounding out a $6 million Series B that began last year. On top of that, it just changed its name from Sialix to Siamab Therapeutics, representing the company’s […]